Menarini Group   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Firenze Italy (1886)

Organization Overview

First Clinical Trial
2005
NCT00942487
First Marketed Drug
2023
elacestrant (Orserdu)
First NDA Approval
2023
elacestrant (Orserdu)
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

A.Menarini Asia-Pacific Holdings Pte Ltd | A. Menarini Industrie Farmaceutiche Riunite S.r.l. | Berlin-Chemie Menarini | Menarini Group | Menarini International Operations Luxembourg SA | Menarini Ricerche S.p.A. - Florence-Italy